Pacira BioSciences Inc
Pacira BioSciences Inc (PCRX) Straddle
PCRX straddle scan found 27 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 54.2%.
Read more
Trading a PCRX straddle lets you take a pure volatility position on Pacira BioSciences Inc without committing to a direction. Pacira BioSciences Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PCRX straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on PCRX profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Pacira BioSciences Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PCRX straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure.
The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the PCRX straddle is the cleanest expression of that view. Our scanner prices every PCRX straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PCRX straddle into a catalyst or short a PCRX straddle to harvest decay, the options straddle setups that matter are all in one place.
| May 21, 2027 | 35.00 | $11.60 | 241 | 9% | 54.2% | $46.60 | $23.40 | 0 |
| May 21, 2027 | 32.50 | $9.98 | 241 | 9% | 52.9% | $42.48 | $22.53 | 0 |
| May 21, 2027 | 30.00 | $8.60 | 241 | 9% | 51.6% | $38.60 | $21.40 | 0 |
| Feb 19, 2027 | 30.00 | $7.50 | 150 | 9% | 50.0% | $37.50 | $22.50 | 0 |
| Jan 15, 2027 | 32.50 | $9.00 | 115 | 9% | 48.9% | $41.50 | $23.50 | 0 |
| May 21, 2027 | 27.50 | $7.78 | 241 | 9% | 48.6% | $35.28 | $19.73 | 0 |
| Jan 15, 2027 | 27.50 | $5.73 | 115 | 9% | 47.9% | $33.23 | $21.78 | 10 |
| Jan 15, 2027 | 30.00 | $7.20 | 115 | 9% | 47.9% | $37.20 | $22.80 | 20 |
| Nov 20, 2026 | 32.50 | $8.45 | 59 | 9% | 47.7% | $40.95 | $24.05 | 0 |
| Oct 16, 2026 | 22.50 | $2.68 | 24 | 9% | 46.8% | $25.18 | $19.83 | 0 |
As of September 23, 2026
Find the right straddle before volatility moves
Track PCRX straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→